中金研究院谢超：耐心资本的本质是风险偏好高

Group 1 - The essence of "patient capital" is a high risk appetite, as statistics show that 70-80% of venture investments fail, indicating that true patient capital must be willing to invest in risky ventures [2][3] - A thriving capital market is a prerequisite for the existence of patient capital, meaning that market prosperity leads to patient capital rather than the other way around [2][6] - The term "patient capital" may create a narrative trap, as it can be misleading to equate patience with patient capital; true patient capital involves a willingness to take risks rather than merely having a long investment horizon [2][3] Group 2 - Wealthy individuals are the primary source of patient capital, as they inherently possess a higher risk appetite, which contributes to the static wealth effect [4] - Pensions are currently a major source of patient capital in the U.S., but they are not naturally inclined to support high-risk investments due to regulatory restrictions and investment strategies focused on matching liabilities [5][6] - The relationship between patient capital and market prosperity is dynamic; a strong market encourages the formation of patient capital, rather than patient capital driving market growth [6] Group 3 - An ideal fundraising structure for venture capital should be based on both dynamic and static wealth effects, requiring technical support and regulatory adjustments to enhance the overall fundraising environment [7] - Government-backed funds currently account for over half of venture capital fundraising, indicating a need for careful management of government involvement to avoid excessive risk aversion [7] - The establishment of a high-yield bond market that aligns with the high-risk nature of technology innovation could potentially enhance the attractiveness of private equity investments, although the lack of public funding support may hinder this [7]